Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline study with acceptable restrictions (5th strain is missing, which has an AT base pair at the primary reversion site. 2-Aminoanthracene is used as the sole indicator of the efficacy of the S9-mix.)

Data source

Reference
Reference Type:
secondary source
Title:
Unnamed
Year:
1996

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
GLP compliance:
not specified
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
3-chloro-o-toluidine
EC Number:
201-756-6
EC Name:
3-chloro-o-toluidine
Cas Number:
87-60-5
Molecular formula:
C7H8ClN
IUPAC Name:
3-chloro-2-methylaniline

Method

Target gene:
his operon
Species / strain
Species / strain / cell type:
S. typhimurium, other: TA 97, TA 98, TA 100 and TA 1535
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats and syrian hamster treated with Aroclor 1254.
Test concentrations with justification for top dose:
0, 3, 10, 33, 100, 333, 666, 1000 µg/plate for strains TA 97 and TA 1535
0, 3, 10, 33, 100, 333, 666, 1000, 1666 µg/plate for strains TA 98 and TA 100
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
Controlsopen allclose all
Untreated negative controls:
not specified
Negative solvent / vehicle controls:
yes
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
other: 2-nitrofluorene or 4-nitro-o-phenylenediamine (TA 98); sodium azide (TA 100 and TA 1535); 9-aminoacridine (TA 97)
Remarks:
without S9 mix
Untreated negative controls:
not specified
Negative solvent / vehicle controls:
yes
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
other: 2-aminoanthracene (all strains)
Remarks:
with S9 mix
Details on test system and experimental conditions:
METHOD OF APPLICATION: preincubation

DURATION
- Preincubation period: 20 minutes at 37°C
- Exposure duration: 48 hours

Results and discussion

Test results
Species / strain:
S. typhimurium, other: TA 97, TA 98, TA 100 and TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
in the highest concentrations tested (see table)
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

TA 100

Dose

No Activation

No Activation

10% HLI

30% HLI

10% RLI

30% RLI

(Negative)

(Negative)

(Negative)

(Negative)

(Negative)

(Negative)

Protocol

Preincubation

Preincubation

Preincubation

Preincubation

Preincubation

Preincubation

µg/Plate

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

0     

128

3.3

118

7.2

123

8

109

3

127

6.1

111

3.7

3     

 

 

119

4

 

 

 

 

 

 

 

 

10     

113

8.3

116

2.4

118

10.8

 

 

109

3.2

 

 

33     

115

7.5

112

2.7

116

11.8

106

3.5

122

4.8

113

4.6

100     

96

6.5

110

3.8

130

6.4

107

4.2

109

14.6

108

4.3

333     

116

3.3

94

5

133

12.7

108

5.5

131

9.5

103

5.8

666     

0x

0

 

 

100

1.2

 

 

113

3

 

 

1000     

 

 

 

 

 

 

104

4.2

 

 

106

1.5

1666     

 

 

 

 

 

 

t

 

 

 

t

 

Positive Control

837

14.4

945

32.2

926

38.5

559

21.4

528

7.5

437

10.6

 

TA 1535

Dose

No Activation

No Activation

10% HLI

30% HLI

10% RLI

30% RLI

(Negative)

(Negative)

(Negative)

(Negative)

(Negative)

(Negative)

Protocol

Preincubation

Preincubation

Preincubation

Preincubation

Preincubation

Preincubation

µg/Plate

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

0     

11

1.5

9

1.7

13

1,5

10

1.9

16

2.3

11

1

3     

8

1.5

11

0.3

 

 

 

 

 

 

 

 

10     

8

0.9

8

1.5

15

2.3

11

1

14

1.5

9

0.7

33     

7

0.6

10

1.5

12

1.2

9

1.2

12

1.5

9

0.9

100     

8

1.5

10

0.7

11

1.8

10

1.9

10

0.7

7

1

333     

7

1

8

0.7

15

2.3

10

2.1

11

1.9

7

0.3

666     

 

 

 

 

6

0.9

 

 

4

0.6

 

 

1000     

 

 

 

 

 

 

7

0.9

 

 

4s

0.6

Positive Control

877

21.1

907

46.4

149

6.7

259

19.7

124

9.5

138

10.1

 

TA 97

Dose

No Activation

No Activation

10% HLI

30% HLI

10% RLI

30% RLI

(Negative)

(Negative)

(Negative)

(Negative)

(Negative)

(Negative)

Protocol

Preincubation

Preincubation

Preincubation

Preincubation

Preincubation

Preincubation

µg/Plate

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

0     

160

9.9

135

6.1

132

13.9

170

7.2

157

11

186

4.6

3     

168

9.7

127

7

 

 

 

 

 

 

 

 

10     

170

8.8

139

0.9

137

9.2

176

7

135

11

181

4.7

33     

176

9.9

143

7.3

156

15.9

180

8.1

159

9.9

187

6

100     

183

6.2

120

9.8

151

5

174

11.5

158

14.7

179

8.3

333     

188

7

98

0.9

140

12.4

181

9

178

5.5

176

10.4

666     

 

 

 

 

118

5.5

 

 

108

1,2

 

 

1000     

 

 

 

 

 

 

179

4.7

 

 

56s

8.9

Positive Control

581

18

583

58.3

1008

27.5

508

6.1

647

20,7

447

15.7

 

TA 98

Dose

No Activation

No Activation

10% HLI

30% HLI

10% RLI

30% RLI

(Negative)

(Negative)

(Negative)

(Negative)

(Negative)

(Negative)

Protocol

Preincubation

Preincubation

Preincubation

Preincubation

Preincubation

Preincubation

µg/Plate

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

Mean

± SEM

0     

17

2

22

3.5

21

2.9

21

2.3

24

3.2

18

2.8

3     

 

 

24

3.2

 

 

 

 

 

 

 

 

10     

18

0.3

26

1.2

16

1.9

 

 

26

3.3

 

 

33     

20

2.9

20

0.7

18

1.7

22

3.3

22

1

18

2.7

100     

18

1.5

24

3.5

24

3.2

20

2.9

27

1.7

22

2.1

333     

18

2.1

25

5.5

22

3.2

19

2.6

24

2.1

16

1.5

666     

x

 

 

 

18

4.3

 

 

22

6.2

 

 

1000     

 

 

 

 

 

 

17

2.2

 

 

15

1.2

1666     

 

 

 

 

 

 

t

 

 

 

t

 

Positive Control

336

11

387

10

760

26.9

534

13.2

438

25.5

514

6.7

 

Abbreviations:

RLI = induced male Sprague Dawley rat liver S9

HLI = induced male Syrian hamster liver S9

s = Slight Toxicity; p = Precipitate; x = Slight Toxicity and Precipitate; T = Toxic; c = Contamination

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative